Grown Rogue International (GRUSF) Retained Earnings (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Retained Earnings of -$44.3 million in Q1 2026, down 6.5% quarter-over-quarter from -$41.6 million in Q4 2025, and down 39.01% on a YoY basis from -$72.6 million in Q1 2025.
Grown Rogue International (GRUSF) Retained Earnings (2009 - 2026) Analysis & Trends
Grown Rogue International's Retained Earnings history runs 18 years deep, the most recent figure standing at -$44.3 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 39.01% year-over-year to -$44.3 million; the TTM figure through Mar 2026 stood at -$44.3 million (down 39.01% YoY), while the FY2025 annual figure was -$41.6 million, down 32905.6% from the prior year.
- Retained Earnings was -$44.3 million for Q1 2026 at Grown Rogue International, down from -$41.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$109613.0 in Q4 2022 to a low of -$27754.9 billion in Q3 2025.
- Historically, Retained Earnings has averaged -$2135.0 billion across 5 years, with a median of -$25.4 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 99.16% in 2024, then sank 108533437.45% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$109613.0 in 2022, then slumped by 13539.32% to -$15.0 million in 2023, then jumped by 99.16% to -$125930.0 in 2024, then plunged by 32905.6% to -$41.6 million in 2025, then retreated by 6.5% to -$44.3 million in 2026.
- The last three Retained Earnings figures came in at -$44.3 million (Q1 2026), -$41.6 million (Q4 2025), and -$27754.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -44.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.27 Mn |
| Dec 31, 2025 | -41.56 Mn |
| Sep 30, 2025 | -27,754.87 Bn |
| Jun 30, 2025 | -30.52 Mn |
| Mar 31, 2025 | -31.84 Mn |
| Dec 31, 2024 | -125,930.00 |
| Sep 30, 2024 | -25.57 Mn |
| Jun 30, 2024 | -25.43 Mn |
| Mar 31, 2024 | -24.55 Mn |
| Dec 31, 2023 | -14.95 Mn |
| Oct 31, 2023 | -114,175.00 |
| Jan 31, 2023 | -19.53 Mn |
| Oct 31, 2022 | -109,613.00 |
| Oct 31, 2021 | 2.36 Mn |
| Apr 30, 2021 | -21.74 Mn |
| Jan 31, 2021 | -20.39 Mn |
| Oct 31, 2020 | -12,197.00 |
| Jul 31, 2020 | -19.31 Mn |
| Apr 30, 2020 | -18.52 Mn |
| Jan 31, 2020 | -17.33 Mn |